Drugs / DS-1211b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05569252 | Oct 2022 → Nov 2023 | pseudoxanthoma elasticum (inherited or acquired) | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-1211b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05569252 ↗ |
| Action | Inhibit | “small-molecule inhibitor of tissue-nonspecific alkaline phosphatase” NCT05569252 ↗ |
| Modality | Small molecule | “potent small-molecule inhibitor of tissue-nonspecific alkaline phosphatase” NCT05569252 ↗ |